| scholarly article | Q13442814 |
| P50 | author | Harry W M Steinbusch | Q55178235 |
| Nico P. Dantuma | Q44287534 | ||
| P2093 | author name string | Denise J H P Hermes | |
| Natalia Kholod | |||
| Nadja Kemmerling | |||
| Fred W van Leeuwen | |||
| Frank J A Dennissen | |||
| P2860 | cites work | Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease | Q44365109 |
| Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. | Q46792024 | ||
| The ubiquitin pathway in Parkinson's disease | Q48015939 | ||
| Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease | Q48219211 | ||
| Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies | Q48676892 | ||
| Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells | Q61788079 | ||
| Microtiter plate transformation using the LiAc/SS carrier DNA/PEG method | Q80078238 | ||
| Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8 | Q24301536 | ||
| Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism | Q24309753 | ||
| UBE3A/E6-AP mutations cause Angelman syndrome | Q24311799 | ||
| Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases | Q24320112 | ||
| Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution | Q24532257 | ||
| Structural basis for the specificity of ubiquitin C-terminal hydrolases | Q27619057 | ||
| Structural Insights into the Assembly and Function of the SAGA Deubiquitinating Module | Q27660560 | ||
| Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels | Q27860531 | ||
| The ubiquitin system | Q27860803 | ||
| Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients | Q28258349 | ||
| Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases | Q28269333 | ||
| A genomic and functional inventory of deubiquitinating enzymes | Q28284911 | ||
| Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR). | Q34104087 | ||
| Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain | Q34274379 | ||
| Tricine-SDS-PAGE. | Q34615345 | ||
| Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains | Q34620363 | ||
| DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination | Q35048728 | ||
| Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation | Q37274327 | ||
| Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology | Q37286190 | ||
| Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. | Q37387675 | ||
| Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates | Q39939165 | ||
| Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation | Q42917499 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurodegeneration | Q1755122 |
| protein catabolic process | Q14876077 | ||
| Ubiquitin C-terminal hydrolase L3 | Q21126400 | ||
| Ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) | Q21991377 | ||
| P304 | page(s) | 2568-74 | |
| P577 | publication date | 2011-08-19 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Mutant ubiquitin (UBB+1) associated with neurodegenerative disorders is hydrolyzed by ubiquitin C-terminal hydrolase L3 (UCH-L3) | |
| P478 | volume | 585 |
| Q35529325 | Accumulation of Basic Amino Acids at Mitochondria Dictates the Cytotoxicity of Aberrant Ubiquitin |
| Q44552006 | Characterizing polyubiquitinated forms of the neurodegenerative ubiquitin mutant UBB+1. |
| Q47262421 | Deposition of mutant ubiquitin in parkinsonism-dementia complex of Guam. |
| Q55315713 | Different Expression Levels of Human Mutant Ubiquitin B+1 (UBB+1) Can Modify Chronological Lifespan or Stress Resistance of Saccharomyces cerevisiae. |
| Q52332790 | Dysfunction of Protein Quality Control in Parkinsonism-Dementia Complex of Guam. |
| Q35739138 | Extended ubiquitin species are protein-based DUB inhibitors |
| Q35668908 | Impacts of Chromatin States and Long-Range Genomic Segments on Aging and DNA Methylation |
| Q26782999 | Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer's disease |
| Q28539822 | Mutant ubiquitin UBB+1 induces mitochondrial fusion by destabilizing mitochondrial fission-specific proteins and confers resistance to oxidative stress-induced cell death in astrocytic cells |
| Q37955915 | Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease. |
| Q38848112 | Role of frameshift ubiquitin B protein in Alzheimer's disease |
| Q26741828 | Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction |
| Q43180105 | Ubiquitin C-terminal hydrolases cleave isopeptide- and peptide-linked ubiquitin from structured proteins but do not edit ubiquitin homopolymers |
| Q38393072 | Ubiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins. |
Search more.